鼻内右美托咪定与口服咪达唑仑预防儿童斜视手术后苏醒期谵妄的随机对照试验
BACKGROUND: Dexmedetomidine is being used increasingly as a premedicant in the paediatric population. However, the effectiveness of pre-operative intranasal dexmedetomidine premedication, compared with oral midazolam, for emergence delirium is not well characterised.…
要点
- 鼻内右美托咪定2 μg/kg降低斜视手术患儿苏醒期谵妄发生率。
- 右美托咪定组术后恶心呕吐发生率低于咪达唑仑组和安慰剂组。
- 各组术后疼痛评分和PACU停留时间无差异。
核心结论
- 斜视手术患儿术前鼻内右美托咪定2 μg/kg相比口服咪达唑仑降低苏醒期谵妄和PONV发生率并提高家长满意度。
主要发现
- 右美托咪定组苏醒期谵妄发生率为11.5%,低于咪达唑仑组的44%(RR=0.262,95%CI 0.116至0.592)和安慰剂组的49%(RR=0.235,95%CI 0.105至0.525)。
- 右美托咪定组PONV发生率为3.8%,低于咪达唑仑组的22%(P=0.006)和安慰剂组的29.4%(P<0.001)。
- 各组术后疼痛评分和PACU停留时间无差异。
关键数值与推荐
- 鼻内右美托咪定剂量为2 μg/kg,口服咪达唑仑剂量为0.5 mg/kg,安慰剂为0.9%生理盐水。
- 主要结局为采用儿童麻醉苏醒期谵妄量表评估的苏醒期谵妄发生率。
临床怎么用
- 斜视手术患儿可考虑术前鼻内右美托咪定2 μg/kg替代口服咪达唑仑以降低苏醒期谵妄和PONV。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexmedetomidine is being used increasingly as a premedicant in the paediatric population. However, the effectiveness of pre-operative intranasal dexmedetomidine premedication, compared with oral midazolam, for emergence delirium is not well characterised. OBJECTIVE: To identify the effectiveness of pre-operative intranasal dexmedetomidine for emergence delirium in the paediatric patient population following general anaesthesia. DESIGN: A prospective, randomised, double-blind, parallel-group, placebo-controlled trial. SETTING: Single university teaching hospital, from September 2013 to August 2014. PATIENTS: One hundred and fifty-six patients undergoing anaesthesia for strabismus surgery were included in the study. INTERVENTION: Patients were randomised in a 1 : 1 : 1 ratio to receive premedication with intranasal dexmedetomidine 2 μg kg (the dexmedetomidine group), oral midazolam 0.5 mg kg (the midazolam group), or 0.9% saline (the placebo group). MAIN OUTCOME MEASURES: The primary outcome was the incidence of emergence delirium assessed by the Paediatric Anaesthesia Emergence Delirium scale. Secondary outcomes included the quality of the inhalational induction, emergence time, postoperative pain intensity, length of stay in the postanaesthesia care unit, the incidence of postoperative nausea or vomiting (PONV) and parents' satisfaction. RESULTS: The incidence of emergence delirium was lower in patients given dexmedetomidine compared with that in patients given midazolam (11.5 versus 44%, relative risk = 0.262, 95% confidence interval 0.116 to 0.592) or 0.9% saline (11.5 versus 49%, relative risk = 0.235, 95% confidence interval 0.105 to 0.525). Likewise, the incidence of PONV was lower in the dexmedetomidine group (3.8%) than that in the midazolam (22%; P = 0.006) or placebo (29.4%; P < 0.001) groups. However, there was no difference among the groups concerning postoperative pain scores and length of postanaesthesia care unit stay. CONCLUSION: In paediatric patients undergoing strabismus surgery intranasal dexmedetomidine 2 μg kg premedication decreases the incidence of emergence delirium and PONV, and improves parents' satisfaction compared with oral midazolam. TRIAL REGISTRATION: ClinicalTrials.gov (identifier: NCT01895023).
引用
- Yao Y, Sun Y, Lin J, et al. Intranasal dexmedetomidine versus oral midazolam premedication to prevent emergence delirium in children undergoing strabismus surgery: A randomised controlled trial. Eur J Anaesthesiol. 2020. PMID: 32976205. doi:10.1097/EJA.0000000000001270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。